-
February 06, 2013
Johnson & Johnson tops the list of drugmakers successfully commercialising their new molecules in a report from consultants at IDEA Pharma
Full story
-
June 07, 2012
The proportion of patients in England spending more than four hours in A&E has increased by over a quarter in the last year, reaching its highest level since 2004, The King's Fund has reported.
Full story
-
May 24, 2012
A new style of leadership in the NHS could deliver lower mortality, better patient outcomes and financial savings, according to a new report.
Full story
-
February 14, 2012
Far from being on a steady slope downward it seems that National Health Service productivity may have actually been on the rise in recent years, suggests an article in the Lancet.
Full story
-
January 17, 2012
Cuts in services for patients are difficult to justify when there are many ways in which hospitals could be improving their efficiency, a major new review has concluded.
Full story
-
January 12, 2012
Access to capital, a burdensome and uncertain regulatory environment and lack of innovation and productivity in R&D are the biggest threats to US biomedical industry growth over the next five years, according to sector leaders.
Full story
-
December 02, 2011
The value generated by a dollar invested in pharmaceutical R&D has fallen by more than 70% in recent years, and the industry is in worse shape than many realise
Full story
-
July 14, 2011
Primary care trusts are not slashing the drugs budget as a cost-cutting move under the NHS’ quality, innovation, productivity and prevention (QIPP) programme, a leading Department of Health official has told PharmaTimes.
Full story
-
November 09, 2010
Speciality drugmaker Shire has been crowned the UK’s most productive healthcare company in a major study by assessment group Profiles International, with biotechnology group BTG second in line.
Full story